{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:17:36Z","timestamp":1793740656215,"version":"4.6.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State","doi-asserted-by":"publisher","award":["E-26\/010.002419\/2019"],"award-info":[{"award-number":["E-26\/010.002419\/2019"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["153\/2024"],"award-info":[{"award-number":["153\/2024"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004612","name":"Araucaria Foundation","doi-asserted-by":"publisher","award":["988\/2024"],"award-info":[{"award-number":["988\/2024"]}],"id":[{"id":"10.13039\/501100004612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/18954\\u20134"],"award-info":[{"award-number":["2018\/18954\\u20134"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2024\/10179\\u20132"],"award-info":[{"award-number":["2024\/10179\\u20132"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2020\/03399\\u20135"],"award-info":[{"award-number":["2020\/03399\\u20135"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.biopha.2025.117956","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T07:41:03Z","timestamp":1742456463000},"page":"117956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Chemotherapy against Toxoplasma gondii: A bibliometric analysis of in vitro and mouse model studies (2015\u20132024)"],"prefix":"10.1016","volume":"186","author":[{"given":"Juliana Quero","family":"Reim\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Ferreira","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie Ortega","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayline","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josinara do Espirito Santo","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo Thiago Ribeiro","family":"Perroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8024-9612","authenticated-orcid":false,"given":"Rafael Meyer","family":"Mariante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.biopha.2025.117956_bib1","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.3390\/foods11162542","article-title":"Toxoplasma gondii in Foods: Prevalence, Control, and Safety","volume":"11","author":"Mar\u00edn-Garc\u00eda","year":"2022","journal-title":"Foods"},{"issue":"1","key":"10.1016\/j.biopha.2025.117956_bib2","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1080\/21505594.2021.2012346","article-title":"The pathogenicity and virulence of Toxoplasma gondii","volume":"12","author":"Sanchez","year":"2021","journal-title":"Virulence"},{"issue":"11","key":"10.1016\/j.biopha.2025.117956_bib3","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.pt.2019.07.001","article-title":"Toxoplasma gondii","volume":"35","author":"Lourido","year":"2019","journal-title":"Trends Parasitol."},{"issue":"1","key":"10.1016\/j.biopha.2025.117956_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011908","article-title":"The role of species ecology in predicting Toxoplasma gondii prevalence in wild and domesticated mammals globally","volume":"20","author":"Wilson","year":"2024","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.biopha.2025.117956_bib5","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3390\/pathogens13100898","article-title":"Ocular toxoplasmosis: advances in Toxoplasma gondii biology, clinical manifestations, diagnostics, and therapy","volume":"13","author":"Miyagaki","year":"2024","journal-title":"Pathogens"},{"issue":"2","key":"10.1016\/j.biopha.2025.117956_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.62641\/aep.v52i2.1658","article-title":"Systematic review on the relationship between toxoplasmosis and mental disorders","volume":"52","author":"Bartolom\u00e9 Del Pino","year":"2024","journal-title":"Actas Esp. Psiquiatr"},{"issue":"4","key":"10.1016\/j.biopha.2025.117956_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin. Microbiol Rev."},{"issue":"2","key":"10.1016\/j.biopha.2025.117956_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1590\/S0074-02762009000200025","article-title":"Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosis","volume":"104","author":"Ch\u00eane","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"2-3","key":"10.1016\/j.biopha.2025.117956_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpara.2020.11.001","article-title":"Control of human toxoplasmosis","volume":"51","author":"Smith","year":"2021","journal-title":"Int J. Parasitol."},{"issue":"4","key":"10.1016\/j.biopha.2025.117956_bib10","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0146-0005(98)80022-0","article-title":"Toxoplasmosis","volume":"22","author":"Beazley","year":"1998","journal-title":"Semin Perinatol."},{"issue":"2","key":"10.1016\/j.biopha.2025.117956_bib11","article-title":"Treatments for toxoplasmosis in pregnancy","volume":"2000","author":"Peyron","year":"1999","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.biopha.2025.117956_bib12","article-title":"Congenital toxoplasmosis: the state of the art","volume":"10","author":"Bollani","year":"2022","journal-title":"Front Pedia"},{"issue":"12","key":"10.1016\/j.biopha.2025.117956_bib13","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.3390\/microorganisms9122531","article-title":"Toxoplasmosis: Current and Emerging Parasite Druggable Targets","volume":"9","author":"Hajj","year":"2021","journal-title":"Microorganisms"},{"issue":"9","key":"10.1016\/j.biopha.2025.117956_bib14","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3390\/microorganisms9091960","article-title":"Promising drug targets and compounds with anti-Toxoplasma gondii activity","volume":"9","author":"Silva","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.biopha.2025.117956_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.974849","article-title":"Drug repositioning: a bibliometric analysis","volume":"13","author":"Sun","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.117956_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jbusres.2021.04.070","article-title":"How to conduct a bibliometric analysis: an overview and guidelines","volume":"133","author":"Donthu","year":"2021","journal-title":"J. Bus. Res"},{"key":"10.1016\/j.biopha.2025.117956_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbusres.2024.114760","article-title":"How to combine and clean bibliometric data and use bibliometric tools synergistically: Guidelines using metaverse research","volume":"182","author":"Lim","year":"2024","journal-title":"J. Bus. Res"},{"issue":"2","key":"10.1016\/j.biopha.2025.117956_bib18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"issue":"4","key":"10.1016\/j.biopha.2025.117956_bib19","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","article-title":"bibliometrix: An R-tool for comprehensive science mapping analysis","volume":"11","author":"Aria","year":"2017","journal-title":"J. Informetr."},{"issue":"3","key":"10.1016\/j.biopha.2025.117956_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/asi.20317","article-title":"Citespace II: detecting and visualizing emerging trends and transient patterns in scientific literature","volume":"57","author":"Chen","year":"2006","journal-title":"J. Am. Soc. Inf. Sci. Technol."},{"issue":"13","key":"10.1016\/j.biopha.2025.117956_bib21","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.1021\/acs.jmedchem.6b00760","article-title":"Development of an orally available and central nervous system (CNS) penetrant Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitor with minimal human ether-a-go-go-related gene (hERG) activity for the treatment of toxoplasmosis","volume":"59","author":"Vidadala","year":"2016","journal-title":"J. Med Chem."},{"issue":"10","key":"10.1016\/j.biopha.2025.117956_bib22","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1128\/AAC.01236-15","article-title":"In vitro and in vivo effects of the bumped kinase inhibitor 1294 in the related cyst-forming apicomplexans Toxoplasma gondii and Neospora caninum","volume":"59","author":"Winzer","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2025.117956_bib23","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2147\/IJN.S158736","article-title":"Anti-Toxoplasma activity of various molecular weights and concentrations of chitosan nanoparticles on tachyzoites of RH strain","volume":"13","author":"Teimouri","year":"2018","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.biopha.2025.117956_bib24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.exppara.2014.12.007","article-title":"Triclosan and triclosan-loaded liposomal nanoparticles in the treatment of acute experimental toxoplasmosis","volume":"149","author":"El-Zawawy","year":"2015","journal-title":"Exp. Parasitol."},{"issue":"5","key":"10.1016\/j.biopha.2025.117956_bib25","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190379","article-title":"Anti-Toxoplasma activity of silver nanoparticles green synthesized with Phoenix dactylifera and Ziziphus spina-christi extracts which inhibits inflammation through liver regulation of cytokines in Balb\/c mice","volume":"39","author":"Alajmi","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.biopha.2025.117956_bib26","doi-asserted-by":"crossref","first-page":"7363","DOI":"10.2147\/IJN.S181896","article-title":"Curcumin nanoemulsion as a novel chemical for the treatment of acute and chronic toxoplasmosis in mice","volume":"13","author":"Azami","year":"2018","journal-title":"Int J. Nanomed."},{"issue":"2","key":"10.1016\/j.biopha.2025.117956_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01640-17","article-title":"Discovery of new inhibitors of Toxoplasma gondii via the pathogen box","volume":"62","author":"Spalenka","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"24","key":"10.1016\/j.biopha.2025.117956_bib28","doi-asserted-by":"crossref","first-page":"9976","DOI":"10.1021\/acs.jmedchem.7b01192","article-title":"Inhibition of calcium dependent protein kinase 1 (CDPK1) by pyrazolopyrimidine analogs decreases establishment and reoccurrence of central nervous system disease by Toxoplasma gondii","volume":"60","author":"Rutaganira","year":"2017","journal-title":"J. Med Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.117956_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00381-19","article-title":"Guanabenz reverses a key behavioral change caused by latent toxoplasmosis in mice by reducing neuroinflammation","volume":"10","author":"Martynowicz","year":"2019","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.biopha.2025.117956_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.15252\/emmm.201607370","article-title":"Targeting Toxoplasma gondii CPSF3 as a new approach to control toxoplasmosis","volume":"9","author":"Palencia","year":"2017","journal-title":"EMBO Mol. Med"},{"issue":"1","key":"10.1016\/j.biopha.2025.117956_bib31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12974-018-1242-1","article-title":"Chronic Toxoplasma infection is associated with distinct alterations in the synaptic protein composition","volume":"15","author":"Lang","year":"2018","journal-title":"J Neuroinflammation"},{"issue":"9425","key":"10.1016\/j.biopha.2025.117956_bib32","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.117956_bib33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: advances, challenges, and current status","volume":"11","author":"Alday","year":"2017","journal-title":"Drug Des. Devel Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.117956_bib34","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12639-017-0973-8","article-title":"Assessment of spiramycin-loaded chitosan nanoparticles treatment on acute and chronic toxoplasmosis in mice","volume":"42","author":"Etewa","year":"2018","journal-title":"J. Parasit. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2025.117956_bib35","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40268-017-0206-8","article-title":"Adverse event profile of pyrimethamine-based therapy in toxoplasmosis: a systematic review","volume":"17","author":"Ben-Harari","year":"2017","journal-title":"Drugs R. D."},{"key":"10.1016\/j.biopha.2025.117956_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fmicb.2017.00025","article-title":"A systematic review of in vitro and in vivo activities of anti-Toxoplasma drugs and compounds (2006-2016)","volume":"8","author":"Montazeri","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.biopha.2025.117956_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115885","article-title":"An updated review of chemical compounds with anti-Toxoplasma gondii activity","volume":"262","author":"Rodriguez","year":"2023","journal-title":"Eur. J. Med Chem."},{"issue":"9","key":"10.1016\/j.biopha.2025.117956_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138204","article-title":"A systematic review and meta-analysis of the efficacy of anti-Toxoplasma gondii medicines in humans","volume":"10","author":"Wei","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2025.117956_bib39","first-page":"174","article-title":"The therapeutic efficacy of curcumin nanoemulsion versus Spiramycin in Toxoplasma gondii (ME49 strain) chronically infected mice","volume":"15","author":"Rageh","year":"2022","journal-title":"Parasitol. U. J."},{"issue":"1","key":"10.1016\/j.biopha.2025.117956_bib40","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12906-024-04522-1","article-title":"In vitro and in vivo anti-parasitic activity of curcumin nanoemulsion on Leishmania major (MRHO\/IR\/75\/ER)","volume":"24","author":"Sahebi","year":"2024","journal-title":"BMC Complement Med Ther."},{"key":"10.1016\/j.biopha.2025.117956_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2023.102810","article-title":"Trichinella spiralis: A new parasitic target for curcumin nanoformulas in mice models","volume":"98","author":"Khedr","year":"2024","journal-title":"Parasitol. Int"},{"issue":"1","key":"10.1016\/j.biopha.2025.117956_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12906-024-04451-z","article-title":"Therapeutic effect of curcumin nanoemulsion on cystic echinococcosis in BALB\/c mice: a computerized tomography (CT) scan and histopathologic study evaluation","volume":"24","author":"Ghanimatdan","year":"2024","journal-title":"BMC Complement Med Ther."},{"key":"10.1016\/j.biopha.2025.117956_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.colcom.2021.100463","article-title":"Nanocomposites: Potential therapeutic agents for the diagnosis and treatment of infectious diseases and cancer","volume":"43","author":"Qamar","year":"2021","journal-title":"Colloid Interface Sci. Commun."},{"issue":"11","key":"10.1016\/j.biopha.2025.117956_bib44","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s10856-020-06429-y","article-title":"Curcumin@metal organic frameworks nano-composite for treatment of chronic toxoplasmosis","volume":"31","author":"El-Shafey","year":"2020","journal-title":"J. Mater. Sci. Mater. Med"},{"key":"10.1016\/j.biopha.2025.117956_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2019.107717","article-title":"Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles","volume":"204","author":"Hagras","year":"2019","journal-title":"Exp. Parasitol."},{"issue":"3","key":"10.1016\/j.biopha.2025.117956_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010268","article-title":"The powerful synergistic effect of spiramycin\/propolis loaded chitosan\/alginate nanoparticles on acute murine toxoplasmosis","volume":"16","author":"Hagras","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2025.117956_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2024.106897","article-title":"Evaluation of the efficacy of Chitosan nanoparticles based on Rosuvastatin in the treatment of acute toxoplasmosis: An In vitro and In vivo study","volume":"195","author":"Norouzi","year":"2024","journal-title":"Micro Pathog."},{"key":"10.1016\/j.biopha.2025.117956_bib48","doi-asserted-by":"crossref","unstructured":"Sadeghi M., Hosseini S.A., Sarvi S., et al. Enhanced clindamycin delivery using chitosan-coated niosomes to prevent Toxoplasma gondii strain VEG in pregnant mice: an experimental study [published correction appears in Trop Med Health. 2024 Oct 15;52(1):71. doi: 10.1186\/s41182-024-00643-y]. Trop Med Health. 2024;52(1):64. doi:10.1186\/s41182-024-00636-x.","DOI":"10.1186\/s41182-024-00643-y"},{"key":"10.1016\/j.biopha.2025.117956_bib49","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejpb.2019.08.015","article-title":"Recent advances in non-ionic surfactant vesicles (niosomes): fabrication, characterization, pharmaceutical and cosmetic applications","volume":"144","author":"Chen","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2025.117956_bib50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.actatropica.2017.10.027","article-title":"Biogenic silver nanoparticles inducing Leishmania amazonensis promastigote and amastigote death in vitro","volume":"178","author":"Fanti","year":"2018","journal-title":"Acta Trop."},{"issue":"8","key":"10.1016\/j.biopha.2025.117956_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255571","article-title":"Efficacy of green synthesized silver nanoparticles via ginger rhizome extract against Leishmania major in vitro","volume":"16","author":"Mohammadi","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.117956_bib52","first-page":"1","article-title":"Pescador-Rojas J, Lucas-G\u00f3mez M, Contreras-Ortiz E, V\u00e1zquez-Chagoy\u00e1n J, Bahena-Uribe D, Aparicio-Burgos J. Evaluaci\u00f3n del efecto antiparasitario de las nanoparticulas de plata contra Trypanosoma cruzi in vitro","volume":"13","year":"2023","journal-title":"Abanico Vet."},{"issue":"12","key":"10.1016\/j.biopha.2025.117956_bib53","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.3390\/nano12122059","article-title":"Silver nanoparticles containing fucoidan synthesized by green method have anti-Trypanosoma cruzi activity","volume":"12","author":"Souza","year":"2022","journal-title":"Nanomater. (Basel)"},{"key":"10.1016\/j.biopha.2025.117956_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.623947","article-title":"Biogenic Silver Nanoparticles Can Control Toxoplasma gondii Infection in Both Human Trophoblast Cells and Villous Explants","volume":"11","author":"Costa","year":"2021","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.biopha.2025.117956_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2022.104971","article-title":"Biogenic silver nanoparticles reduce Toxoplasma gondii infection and proliferation in RAW 264.7 macrophages by inducing tumor necrosis factor-alpha and reactive oxygen species production in the cells","volume":"24","author":"Arruda da Silva Sanfelice","year":"2022","journal-title":"Microbes Infect."},{"issue":"1","key":"10.1016\/j.biopha.2025.117956_bib56","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1080\/14756366.2022.2115035","article-title":"Arctigenin: pharmacology, total synthesis, and progress in structure modification","volume":"37","author":"Wu","year":"2022","journal-title":"J. Enzym. Inhib. Med Chem."},{"key":"10.1016\/j.biopha.2025.117956_bib57","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ejmech.2018.08.087","article-title":"Synthesis and evaluation of novel arctigenin derivatives as potential anti-Toxoplasma gondii agents","volume":"158","author":"Zhang","year":"2018","journal-title":"Eur. J. Med Chem."},{"issue":"21","key":"10.1016\/j.biopha.2025.117956_bib58","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1080\/14786419.2022.2098497","article-title":"Synthesis and evaluation of in vitro and in vivo anti-Toxoplasma gondii activity of tetraoxane-substituted ursolic acid derivatives","volume":"37","author":"Wang","year":"2023","journal-title":"Nat. Prod. Res"},{"key":"10.1016\/j.biopha.2025.117956_bib59","article-title":"Synthesis and anti-Toxoplasma activity of indole-triazole compounds on tachyzoites of RH strain","volume":"74","author":"Bahreini","year":"2022","journal-title":"Ann. Med Surg. (Lond. )"},{"issue":"1","key":"10.1016\/j.biopha.2025.117956_bib60","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41598-024-82787-9","article-title":"Discovery of potent anti-toxoplasmosis drugs from secondary metabolites in Citrus limon (lemon) leaves, supported in-silico study","volume":"15","author":"Mohammed","year":"2025","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2025.117956_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011350","article-title":"Dimethyl itaconate ameliorates the deficits of goal-directed behavior in Toxoplasma gondii infected mice","volume":"17","author":"Wu","year":"2023","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2025.117956_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1043572","article-title":"A metabolite attenuates neuroinflammation, synaptic loss and cognitive deficits induced by chronic infection of Toxoplasma gondii","volume":"13","author":"He","year":"2022","journal-title":"Front Immunol."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2025.118483","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:01:54Z","timestamp":1781823714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225001507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":62,"alternative-id":["S0753332225001507"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117956","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemotherapy against Toxoplasma gondii: A bibliometric analysis of in vitro and mouse model studies (2015\u20132024)","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117956","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117956"}}